Therapeutic monitoring of immunosuppressive drugs in pediatric patients: special considerations

Expert Rev Clin Pharmacol. 2016 Aug;9(8):1001-3. doi: 10.1080/17512433.2016.1193434. Epub 2016 Jun 6.

Authors

L T Weber¹, J Dötsch¹

Affiliation

¹ a Childrens' and Adolescents' Hospital , University Hospital of Cologne , Cologne , Germany.

PMID: 27224663
DOI: 10.1080/17512433.2016.1193434

No abstract available

Keywords: Children; biomarkers; pharmacodynamics; pharmacogenetics; pharmacokinetics.

MeSH terms

Age Factors
Child
Dose-Response Relationship, Drug
Drug Monitoring / methods*
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / pharmacokinetics*

Substances

Immunosuppressive Agents